Endothelial to Mesenchymal Transition in Cardiovascular Disease

Kovacic, Jason C and Dimmeler, Stefanie and Harvey, Richard P and Finkel, Toren and Aikawa, Elena and Krenning, Guido and Baker, Andrew H (2019) Endothelial to Mesenchymal Transition in Cardiovascular Disease. Journal of the American College of Cardiology, 73 (2). pp.190-209. ISSN 1558-3597 (Not OA)

Full text not available from this repository.
Link to published document: http://doi.org/10.1016/j.jacc.2018.09.089

Abstract

Endothelial to mesenchymal transition (EndMT) is a process whereby an endothelial cell undergoes a series of molecular events that lead to a change in phenotype toward a mesenchymal cell (e.g., myofibroblast, smooth muscle cell). EndMT plays a fundamental role during development, and mounting evidence indicates that EndMT is involved in adult cardiovascular diseases (CVDs), including atherosclerosis, pulmonary hypertension, valvular disease, and fibroelastosis. Therefore, the targeting of EndMT may hold therapeutic promise for treating CVD. However, the field faces a number of challenges, including the lack of a precise functional and molecular definition, a lack of understanding of the causative pathological role of EndMT in CVDs (versus being a "bystander-phenomenon"), and a lack of robust human data corroborating the extent and causality of EndMT in adult CVDs. Here, we review this emerging but exciting field, and propose a framework for its systematic advancement at the molecular and translational levels.

Item Type: Article
Subjects: R Medicine > R Medicine (General)
Depositing User: Repository Administrator
Date Deposited: 22 Jan 2019 04:57
Last Modified: 22 Jan 2019 04:57
URI: https://eprints.victorchang.edu.au/id/eprint/799

Actions (login required)

View Item View Item